Taub Rebecca sold MDGL
January 9, 2026 · Form 4 insider transaction
Taub Rebecca sold 40 shares of Madrigal Pharmaceuticals, Inc. at $545.79 per share, a transaction worth $21.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
40
Price
$545.79
Total value
$21.8K
InsiderTaub Rebecca
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 9, 2026
Filing dateJanuary 13, 2026
Shares owned after455,789
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.